Please try another search
Investment Banking & Investment Services
Financial
ETF
Kodex Synth US Biotech is an exchange traded fund launched and managed by Samsung Asset Management Co. Ltd. The fund invests in public equity markets of the United States. It uses derivatives such as swaps to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It replicates the performance of the S&P Biotechnology Select Industry Index, by using synthetic replication methodology. Kodex Synth US Biotech was formed on October 30, 2013 and is domiciled in South Korea.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review